Medical Care
Global Metastatic Colorectal Cancer Treatment Market Research Report 2024
- Jan 20, 24
- ID: 20204
- Pages: 84
- Figures: 168
- Views: 26
Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body parts i.e. metastatic colorectal cancers are difficult to treat and have 11%-12% 5-year relative survival rate.
The global Metastatic Colorectal Cancer Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Metastatic Colorectal Cancer Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metastatic Colorectal Cancer Treatment.
Report Scope
The Metastatic Colorectal Cancer Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Metastatic Colorectal Cancer Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Metastatic Colorectal Cancer Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Roche
Eli Lilly
Pfizer
Novartis
Amgen
Taiho Oncology
Genentech
EMD Serono
Suzhou Zelgen Biopharmaceuticals
Segment by Type
Surgery
Chemotherapy
Segment by Application
Hospitals
Clinics
Cancer Research Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Metastatic Colorectal Cancer Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Metastatic Colorectal Cancer Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Metastatic Colorectal Cancer Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metastatic Colorectal Cancer Treatment.
Report Scope
The Metastatic Colorectal Cancer Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Metastatic Colorectal Cancer Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Metastatic Colorectal Cancer Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Roche
Eli Lilly
Pfizer
Novartis
Amgen
Taiho Oncology
Genentech
EMD Serono
Suzhou Zelgen Biopharmaceuticals
Segment by Type
Surgery
Chemotherapy
Segment by Application
Hospitals
Clinics
Cancer Research Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Metastatic Colorectal Cancer Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Metastatic Colorectal Cancer Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Surgery
1.2.3 Chemotherapy
1.3 Market by Application
1.3.1 Global Metastatic Colorectal Cancer Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Cancer Research Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Metastatic Colorectal Cancer Treatment Market Perspective (2019-2030)
2.2 Metastatic Colorectal Cancer Treatment Growth Trends by Region
2.2.1 Global Metastatic Colorectal Cancer Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Metastatic Colorectal Cancer Treatment Historic Market Size by Region (2019-2024)
2.2.3 Metastatic Colorectal Cancer Treatment Forecasted Market Size by Region (2025-2030)
2.3 Metastatic Colorectal Cancer Treatment Market Dynamics
2.3.1 Metastatic Colorectal Cancer Treatment Industry Trends
2.3.2 Metastatic Colorectal Cancer Treatment Market Drivers
2.3.3 Metastatic Colorectal Cancer Treatment Market Challenges
2.3.4 Metastatic Colorectal Cancer Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Metastatic Colorectal Cancer Treatment Players by Revenue
3.1.1 Global Top Metastatic Colorectal Cancer Treatment Players by Revenue (2019-2024)
3.1.2 Global Metastatic Colorectal Cancer Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Metastatic Colorectal Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Metastatic Colorectal Cancer Treatment Revenue
3.4 Global Metastatic Colorectal Cancer Treatment Market Concentration Ratio
3.4.1 Global Metastatic Colorectal Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Metastatic Colorectal Cancer Treatment Revenue in 2023
3.5 Metastatic Colorectal Cancer Treatment Key Players Head office and Area Served
3.6 Key Players Metastatic Colorectal Cancer Treatment Product Solution and Service
3.7 Date of Enter into Metastatic Colorectal Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Metastatic Colorectal Cancer Treatment Breakdown Data by Type
4.1 Global Metastatic Colorectal Cancer Treatment Historic Market Size by Type (2019-2024)
4.2 Global Metastatic Colorectal Cancer Treatment Forecasted Market Size by Type (2025-2030)
5 Metastatic Colorectal Cancer Treatment Breakdown Data by Application
5.1 Global Metastatic Colorectal Cancer Treatment Historic Market Size by Application (2019-2024)
5.2 Global Metastatic Colorectal Cancer Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Metastatic Colorectal Cancer Treatment Market Size (2019-2030)
6.2 North America Metastatic Colorectal Cancer Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Metastatic Colorectal Cancer Treatment Market Size by Country (2019-2024)
6.4 North America Metastatic Colorectal Cancer Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Metastatic Colorectal Cancer Treatment Market Size (2019-2030)
7.2 Europe Metastatic Colorectal Cancer Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Metastatic Colorectal Cancer Treatment Market Size by Country (2019-2024)
7.4 Europe Metastatic Colorectal Cancer Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size (2019-2030)
8.2 Asia-Pacific Metastatic Colorectal Cancer Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Metastatic Colorectal Cancer Treatment Market Size (2019-2030)
9.2 Latin America Metastatic Colorectal Cancer Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Metastatic Colorectal Cancer Treatment Market Size by Country (2019-2024)
9.4 Latin America Metastatic Colorectal Cancer Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size (2019-2030)
10.2 Middle East & Africa Metastatic Colorectal Cancer Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Detail
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Metastatic Colorectal Cancer Treatment Introduction
11.1.4 Sanofi Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024)
11.1.5 Sanofi Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Metastatic Colorectal Cancer Treatment Introduction
11.2.4 Roche Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024)
11.2.5 Roche Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Detail
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Metastatic Colorectal Cancer Treatment Introduction
11.3.4 Eli Lilly Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024)
11.3.5 Eli Lilly Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Metastatic Colorectal Cancer Treatment Introduction
11.4.4 Pfizer Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024)
11.4.5 Pfizer Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis Metastatic Colorectal Cancer Treatment Introduction
11.5.4 Novartis Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024)
11.5.5 Novartis Recent Development
11.6 Amgen
11.6.1 Amgen Company Detail
11.6.2 Amgen Business Overview
11.6.3 Amgen Metastatic Colorectal Cancer Treatment Introduction
11.6.4 Amgen Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024)
11.6.5 Amgen Recent Development
11.7 Taiho Oncology
11.7.1 Taiho Oncology Company Detail
11.7.2 Taiho Oncology Business Overview
11.7.3 Taiho Oncology Metastatic Colorectal Cancer Treatment Introduction
11.7.4 Taiho Oncology Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024)
11.7.5 Taiho Oncology Recent Development
11.8 Genentech
11.8.1 Genentech Company Detail
11.8.2 Genentech Business Overview
11.8.3 Genentech Metastatic Colorectal Cancer Treatment Introduction
11.8.4 Genentech Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024)
11.8.5 Genentech Recent Development
11.9 EMD Serono
11.9.1 EMD Serono Company Detail
11.9.2 EMD Serono Business Overview
11.9.3 EMD Serono Metastatic Colorectal Cancer Treatment Introduction
11.9.4 EMD Serono Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024)
11.9.5 EMD Serono Recent Development
11.10 Suzhou Zelgen Biopharmaceuticals
11.10.1 Suzhou Zelgen Biopharmaceuticals Company Detail
11.10.2 Suzhou Zelgen Biopharmaceuticals Business Overview
11.10.3 Suzhou Zelgen Biopharmaceuticals Metastatic Colorectal Cancer Treatment Introduction
11.10.4 Suzhou Zelgen Biopharmaceuticals Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024)
11.10.5 Suzhou Zelgen Biopharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Metastatic Colorectal Cancer Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Surgery
1.2.3 Chemotherapy
1.3 Market by Application
1.3.1 Global Metastatic Colorectal Cancer Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Cancer Research Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Metastatic Colorectal Cancer Treatment Market Perspective (2019-2030)
2.2 Metastatic Colorectal Cancer Treatment Growth Trends by Region
2.2.1 Global Metastatic Colorectal Cancer Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Metastatic Colorectal Cancer Treatment Historic Market Size by Region (2019-2024)
2.2.3 Metastatic Colorectal Cancer Treatment Forecasted Market Size by Region (2025-2030)
2.3 Metastatic Colorectal Cancer Treatment Market Dynamics
2.3.1 Metastatic Colorectal Cancer Treatment Industry Trends
2.3.2 Metastatic Colorectal Cancer Treatment Market Drivers
2.3.3 Metastatic Colorectal Cancer Treatment Market Challenges
2.3.4 Metastatic Colorectal Cancer Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Metastatic Colorectal Cancer Treatment Players by Revenue
3.1.1 Global Top Metastatic Colorectal Cancer Treatment Players by Revenue (2019-2024)
3.1.2 Global Metastatic Colorectal Cancer Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Metastatic Colorectal Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Metastatic Colorectal Cancer Treatment Revenue
3.4 Global Metastatic Colorectal Cancer Treatment Market Concentration Ratio
3.4.1 Global Metastatic Colorectal Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Metastatic Colorectal Cancer Treatment Revenue in 2023
3.5 Metastatic Colorectal Cancer Treatment Key Players Head office and Area Served
3.6 Key Players Metastatic Colorectal Cancer Treatment Product Solution and Service
3.7 Date of Enter into Metastatic Colorectal Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Metastatic Colorectal Cancer Treatment Breakdown Data by Type
4.1 Global Metastatic Colorectal Cancer Treatment Historic Market Size by Type (2019-2024)
4.2 Global Metastatic Colorectal Cancer Treatment Forecasted Market Size by Type (2025-2030)
5 Metastatic Colorectal Cancer Treatment Breakdown Data by Application
5.1 Global Metastatic Colorectal Cancer Treatment Historic Market Size by Application (2019-2024)
5.2 Global Metastatic Colorectal Cancer Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Metastatic Colorectal Cancer Treatment Market Size (2019-2030)
6.2 North America Metastatic Colorectal Cancer Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Metastatic Colorectal Cancer Treatment Market Size by Country (2019-2024)
6.4 North America Metastatic Colorectal Cancer Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Metastatic Colorectal Cancer Treatment Market Size (2019-2030)
7.2 Europe Metastatic Colorectal Cancer Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Metastatic Colorectal Cancer Treatment Market Size by Country (2019-2024)
7.4 Europe Metastatic Colorectal Cancer Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size (2019-2030)
8.2 Asia-Pacific Metastatic Colorectal Cancer Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Metastatic Colorectal Cancer Treatment Market Size (2019-2030)
9.2 Latin America Metastatic Colorectal Cancer Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Metastatic Colorectal Cancer Treatment Market Size by Country (2019-2024)
9.4 Latin America Metastatic Colorectal Cancer Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size (2019-2030)
10.2 Middle East & Africa Metastatic Colorectal Cancer Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Detail
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Metastatic Colorectal Cancer Treatment Introduction
11.1.4 Sanofi Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024)
11.1.5 Sanofi Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Metastatic Colorectal Cancer Treatment Introduction
11.2.4 Roche Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024)
11.2.5 Roche Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Detail
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Metastatic Colorectal Cancer Treatment Introduction
11.3.4 Eli Lilly Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024)
11.3.5 Eli Lilly Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Metastatic Colorectal Cancer Treatment Introduction
11.4.4 Pfizer Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024)
11.4.5 Pfizer Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis Metastatic Colorectal Cancer Treatment Introduction
11.5.4 Novartis Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024)
11.5.5 Novartis Recent Development
11.6 Amgen
11.6.1 Amgen Company Detail
11.6.2 Amgen Business Overview
11.6.3 Amgen Metastatic Colorectal Cancer Treatment Introduction
11.6.4 Amgen Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024)
11.6.5 Amgen Recent Development
11.7 Taiho Oncology
11.7.1 Taiho Oncology Company Detail
11.7.2 Taiho Oncology Business Overview
11.7.3 Taiho Oncology Metastatic Colorectal Cancer Treatment Introduction
11.7.4 Taiho Oncology Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024)
11.7.5 Taiho Oncology Recent Development
11.8 Genentech
11.8.1 Genentech Company Detail
11.8.2 Genentech Business Overview
11.8.3 Genentech Metastatic Colorectal Cancer Treatment Introduction
11.8.4 Genentech Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024)
11.8.5 Genentech Recent Development
11.9 EMD Serono
11.9.1 EMD Serono Company Detail
11.9.2 EMD Serono Business Overview
11.9.3 EMD Serono Metastatic Colorectal Cancer Treatment Introduction
11.9.4 EMD Serono Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024)
11.9.5 EMD Serono Recent Development
11.10 Suzhou Zelgen Biopharmaceuticals
11.10.1 Suzhou Zelgen Biopharmaceuticals Company Detail
11.10.2 Suzhou Zelgen Biopharmaceuticals Business Overview
11.10.3 Suzhou Zelgen Biopharmaceuticals Metastatic Colorectal Cancer Treatment Introduction
11.10.4 Suzhou Zelgen Biopharmaceuticals Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024)
11.10.5 Suzhou Zelgen Biopharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Metastatic Colorectal Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Surgery
Table 3. Key Players of Chemotherapy
Table 4. Global Metastatic Colorectal Cancer Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Metastatic Colorectal Cancer Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Metastatic Colorectal Cancer Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Metastatic Colorectal Cancer Treatment Market Share by Region (2019-2024)
Table 8. Global Metastatic Colorectal Cancer Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Metastatic Colorectal Cancer Treatment Market Share by Region (2025-2030)
Table 10. Metastatic Colorectal Cancer Treatment Market Trends
Table 11. Metastatic Colorectal Cancer Treatment Market Drivers
Table 12. Metastatic Colorectal Cancer Treatment Market Challenges
Table 13. Metastatic Colorectal Cancer Treatment Market Restraints
Table 14. Global Metastatic Colorectal Cancer Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Metastatic Colorectal Cancer Treatment Market Share by Players (2019-2024)
Table 16. Global Top Metastatic Colorectal Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metastatic Colorectal Cancer Treatment as of 2023)
Table 17. Ranking of Global Top Metastatic Colorectal Cancer Treatment Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Metastatic Colorectal Cancer Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Metastatic Colorectal Cancer Treatment Product Solution and Service
Table 21. Date of Enter into Metastatic Colorectal Cancer Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Metastatic Colorectal Cancer Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Metastatic Colorectal Cancer Treatment Revenue Market Share by Type (2019-2024)
Table 25. Global Metastatic Colorectal Cancer Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Metastatic Colorectal Cancer Treatment Revenue Market Share by Type (2025-2030)
Table 27. Global Metastatic Colorectal Cancer Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Metastatic Colorectal Cancer Treatment Revenue Market Share by Application (2019-2024)
Table 29. Global Metastatic Colorectal Cancer Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Metastatic Colorectal Cancer Treatment Revenue Market Share by Application (2025-2030)
Table 31. North America Metastatic Colorectal Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Metastatic Colorectal Cancer Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Metastatic Colorectal Cancer Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Metastatic Colorectal Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Metastatic Colorectal Cancer Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Metastatic Colorectal Cancer Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Metastatic Colorectal Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Metastatic Colorectal Cancer Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Metastatic Colorectal Cancer Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 46. Sanofi Company Detail
Table 47. Sanofi Business Overview
Table 48. Sanofi Metastatic Colorectal Cancer Treatment Product
Table 49. Sanofi Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024) & (US$ Million)
Table 50. Sanofi Recent Development
Table 51. Roche Company Detail
Table 52. Roche Business Overview
Table 53. Roche Metastatic Colorectal Cancer Treatment Product
Table 54. Roche Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024) & (US$ Million)
Table 55. Roche Recent Development
Table 56. Eli Lilly Company Detail
Table 57. Eli Lilly Business Overview
Table 58. Eli Lilly Metastatic Colorectal Cancer Treatment Product
Table 59. Eli Lilly Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024) & (US$ Million)
Table 60. Eli Lilly Recent Development
Table 61. Pfizer Company Detail
Table 62. Pfizer Business Overview
Table 63. Pfizer Metastatic Colorectal Cancer Treatment Product
Table 64. Pfizer Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Novartis Company Detail
Table 67. Novartis Business Overview
Table 68. Novartis Metastatic Colorectal Cancer Treatment Product
Table 69. Novartis Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024) & (US$ Million)
Table 70. Novartis Recent Development
Table 71. Amgen Company Detail
Table 72. Amgen Business Overview
Table 73. Amgen Metastatic Colorectal Cancer Treatment Product
Table 74. Amgen Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024) & (US$ Million)
Table 75. Amgen Recent Development
Table 76. Taiho Oncology Company Detail
Table 77. Taiho Oncology Business Overview
Table 78. Taiho Oncology Metastatic Colorectal Cancer Treatment Product
Table 79. Taiho Oncology Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024) & (US$ Million)
Table 80. Taiho Oncology Recent Development
Table 81. Genentech Company Detail
Table 82. Genentech Business Overview
Table 83. Genentech Metastatic Colorectal Cancer Treatment Product
Table 84. Genentech Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024) & (US$ Million)
Table 85. Genentech Recent Development
Table 86. EMD Serono Company Detail
Table 87. EMD Serono Business Overview
Table 88. EMD Serono Metastatic Colorectal Cancer Treatment Product
Table 89. EMD Serono Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024) & (US$ Million)
Table 90. EMD Serono Recent Development
Table 91. Suzhou Zelgen Biopharmaceuticals Company Detail
Table 92. Suzhou Zelgen Biopharmaceuticals Business Overview
Table 93. Suzhou Zelgen Biopharmaceuticals Metastatic Colorectal Cancer Treatment Product
Table 94. Suzhou Zelgen Biopharmaceuticals Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024) & (US$ Million)
Table 95. Suzhou Zelgen Biopharmaceuticals Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Metastatic Colorectal Cancer Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Metastatic Colorectal Cancer Treatment Market Share by Type: 2023 VS 2030
Figure 3. Surgery Features
Figure 4. Chemotherapy Features
Figure 5. Global Metastatic Colorectal Cancer Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Metastatic Colorectal Cancer Treatment Market Share by Application: 2023 VS 2030
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Cancer Research Centers Case Studies
Figure 10. Metastatic Colorectal Cancer Treatment Report Years Considered
Figure 11. Global Metastatic Colorectal Cancer Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Metastatic Colorectal Cancer Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Metastatic Colorectal Cancer Treatment Market Share by Region: 2023 VS 2030
Figure 14. Global Metastatic Colorectal Cancer Treatment Market Share by Players in 2023
Figure 15. Global Top Metastatic Colorectal Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metastatic Colorectal Cancer Treatment as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Metastatic Colorectal Cancer Treatment Revenue in 2023
Figure 17. North America Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Metastatic Colorectal Cancer Treatment Market Share by Country (2019-2030)
Figure 19. United States Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Metastatic Colorectal Cancer Treatment Market Share by Country (2019-2030)
Figure 23. Germany Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Metastatic Colorectal Cancer Treatment Market Share by Region (2019-2030)
Figure 31. China Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Metastatic Colorectal Cancer Treatment Market Share by Country (2019-2030)
Figure 39. Mexico Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Metastatic Colorectal Cancer Treatment Market Share by Country (2019-2030)
Figure 43. Turkey Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Sanofi Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2019-2024)
Figure 46. Roche Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2019-2024)
Figure 47. Eli Lilly Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2019-2024)
Figure 48. Pfizer Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2019-2024)
Figure 49. Novartis Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2019-2024)
Figure 50. Amgen Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2019-2024)
Figure 51. Taiho Oncology Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2019-2024)
Figure 52. Genentech Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2019-2024)
Figure 53. EMD Serono Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2019-2024)
Figure 54. Suzhou Zelgen Biopharmaceuticals Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2019-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Table 1. Global Metastatic Colorectal Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Surgery
Table 3. Key Players of Chemotherapy
Table 4. Global Metastatic Colorectal Cancer Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Metastatic Colorectal Cancer Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Metastatic Colorectal Cancer Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Metastatic Colorectal Cancer Treatment Market Share by Region (2019-2024)
Table 8. Global Metastatic Colorectal Cancer Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Metastatic Colorectal Cancer Treatment Market Share by Region (2025-2030)
Table 10. Metastatic Colorectal Cancer Treatment Market Trends
Table 11. Metastatic Colorectal Cancer Treatment Market Drivers
Table 12. Metastatic Colorectal Cancer Treatment Market Challenges
Table 13. Metastatic Colorectal Cancer Treatment Market Restraints
Table 14. Global Metastatic Colorectal Cancer Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Metastatic Colorectal Cancer Treatment Market Share by Players (2019-2024)
Table 16. Global Top Metastatic Colorectal Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metastatic Colorectal Cancer Treatment as of 2023)
Table 17. Ranking of Global Top Metastatic Colorectal Cancer Treatment Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Metastatic Colorectal Cancer Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Metastatic Colorectal Cancer Treatment Product Solution and Service
Table 21. Date of Enter into Metastatic Colorectal Cancer Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Metastatic Colorectal Cancer Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Metastatic Colorectal Cancer Treatment Revenue Market Share by Type (2019-2024)
Table 25. Global Metastatic Colorectal Cancer Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Metastatic Colorectal Cancer Treatment Revenue Market Share by Type (2025-2030)
Table 27. Global Metastatic Colorectal Cancer Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Metastatic Colorectal Cancer Treatment Revenue Market Share by Application (2019-2024)
Table 29. Global Metastatic Colorectal Cancer Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Metastatic Colorectal Cancer Treatment Revenue Market Share by Application (2025-2030)
Table 31. North America Metastatic Colorectal Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Metastatic Colorectal Cancer Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Metastatic Colorectal Cancer Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Metastatic Colorectal Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Metastatic Colorectal Cancer Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Metastatic Colorectal Cancer Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Metastatic Colorectal Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Metastatic Colorectal Cancer Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Metastatic Colorectal Cancer Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 46. Sanofi Company Detail
Table 47. Sanofi Business Overview
Table 48. Sanofi Metastatic Colorectal Cancer Treatment Product
Table 49. Sanofi Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024) & (US$ Million)
Table 50. Sanofi Recent Development
Table 51. Roche Company Detail
Table 52. Roche Business Overview
Table 53. Roche Metastatic Colorectal Cancer Treatment Product
Table 54. Roche Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024) & (US$ Million)
Table 55. Roche Recent Development
Table 56. Eli Lilly Company Detail
Table 57. Eli Lilly Business Overview
Table 58. Eli Lilly Metastatic Colorectal Cancer Treatment Product
Table 59. Eli Lilly Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024) & (US$ Million)
Table 60. Eli Lilly Recent Development
Table 61. Pfizer Company Detail
Table 62. Pfizer Business Overview
Table 63. Pfizer Metastatic Colorectal Cancer Treatment Product
Table 64. Pfizer Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Novartis Company Detail
Table 67. Novartis Business Overview
Table 68. Novartis Metastatic Colorectal Cancer Treatment Product
Table 69. Novartis Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024) & (US$ Million)
Table 70. Novartis Recent Development
Table 71. Amgen Company Detail
Table 72. Amgen Business Overview
Table 73. Amgen Metastatic Colorectal Cancer Treatment Product
Table 74. Amgen Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024) & (US$ Million)
Table 75. Amgen Recent Development
Table 76. Taiho Oncology Company Detail
Table 77. Taiho Oncology Business Overview
Table 78. Taiho Oncology Metastatic Colorectal Cancer Treatment Product
Table 79. Taiho Oncology Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024) & (US$ Million)
Table 80. Taiho Oncology Recent Development
Table 81. Genentech Company Detail
Table 82. Genentech Business Overview
Table 83. Genentech Metastatic Colorectal Cancer Treatment Product
Table 84. Genentech Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024) & (US$ Million)
Table 85. Genentech Recent Development
Table 86. EMD Serono Company Detail
Table 87. EMD Serono Business Overview
Table 88. EMD Serono Metastatic Colorectal Cancer Treatment Product
Table 89. EMD Serono Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024) & (US$ Million)
Table 90. EMD Serono Recent Development
Table 91. Suzhou Zelgen Biopharmaceuticals Company Detail
Table 92. Suzhou Zelgen Biopharmaceuticals Business Overview
Table 93. Suzhou Zelgen Biopharmaceuticals Metastatic Colorectal Cancer Treatment Product
Table 94. Suzhou Zelgen Biopharmaceuticals Revenue in Metastatic Colorectal Cancer Treatment Business (2019-2024) & (US$ Million)
Table 95. Suzhou Zelgen Biopharmaceuticals Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Metastatic Colorectal Cancer Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Metastatic Colorectal Cancer Treatment Market Share by Type: 2023 VS 2030
Figure 3. Surgery Features
Figure 4. Chemotherapy Features
Figure 5. Global Metastatic Colorectal Cancer Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Metastatic Colorectal Cancer Treatment Market Share by Application: 2023 VS 2030
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Cancer Research Centers Case Studies
Figure 10. Metastatic Colorectal Cancer Treatment Report Years Considered
Figure 11. Global Metastatic Colorectal Cancer Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Metastatic Colorectal Cancer Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Metastatic Colorectal Cancer Treatment Market Share by Region: 2023 VS 2030
Figure 14. Global Metastatic Colorectal Cancer Treatment Market Share by Players in 2023
Figure 15. Global Top Metastatic Colorectal Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metastatic Colorectal Cancer Treatment as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Metastatic Colorectal Cancer Treatment Revenue in 2023
Figure 17. North America Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Metastatic Colorectal Cancer Treatment Market Share by Country (2019-2030)
Figure 19. United States Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Metastatic Colorectal Cancer Treatment Market Share by Country (2019-2030)
Figure 23. Germany Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Metastatic Colorectal Cancer Treatment Market Share by Region (2019-2030)
Figure 31. China Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Metastatic Colorectal Cancer Treatment Market Share by Country (2019-2030)
Figure 39. Mexico Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Metastatic Colorectal Cancer Treatment Market Share by Country (2019-2030)
Figure 43. Turkey Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Sanofi Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2019-2024)
Figure 46. Roche Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2019-2024)
Figure 47. Eli Lilly Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2019-2024)
Figure 48. Pfizer Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2019-2024)
Figure 49. Novartis Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2019-2024)
Figure 50. Amgen Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2019-2024)
Figure 51. Taiho Oncology Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2019-2024)
Figure 52. Genentech Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2019-2024)
Figure 53. EMD Serono Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2019-2024)
Figure 54. Suzhou Zelgen Biopharmaceuticals Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2019-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232